Biotech company Biogen lowered its full-year profit forecast, citing higher costs related to its purchase of drug maker Reata Pharmaceuticals as well as the launch of its Alzheimer's drug.
Share:
More In Business
Cheddar Afternoon News Briefings of April 21st
Cheddar Afternoon News Briefings
BuzzFeed News to Be Shuttered in Corporate Cost Cutting Move
Pulitzer Prize winning digital media outlet BuzzFeed News is being shut down as part of a cost-cutting drive by its corporate parent that’s shedding about 15% of its entire staff, adding to layoffs made earlier this year.
Calling Beer Champagne Leaves French Producers Frothing
Belgian customs have destroyed more than 2,000 cans of Miller High Life, advertised as the ″Champagne of Beers,” at the request of houses and growers of the bubbly beverage.
Stock Market Today: Stocks Close Quiet With Small Gains
Stocks remained listless in afternoon trading Friday, as Wall Street closed out a quiet week highlighted by a batch of mostly mixed corporate earnings reports.
Elon Musk's Twitter Drops Government-Funded Media Labels
Twitter has removed labels describing global media organizations are government-funded or state-affiliated.
Cheddar Morning News Briefings of April 21st
Cheddar Morning News Briefings
Morning Alexa Flash Briefings of April 21st
Morning Alexa Flash Briefings
Stretching Your Dollar: Credit Card Debt Surpasses Excess Savings
Caleb Silver, editor-in-chief of Investopedia, joined Cheddar News to discuss the rising credit card debt that Americans hold as high-interest rates and continued inflation affect households.
New Yorkers Can Finally Buy Legal Cannabis on 420
For the first time on the unofficial cannabis holiday 420, cannabis enthusiasts in New York State can purchase their products legally. One of the first licensed adult-use dispensaries across the state was buzzing with business early in the day.
